EUVIMEDEUVIMED entdecken
Open Access

Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV

Andrew W Hahn iD, S A Ruderman, R M Nance, B M Whitney, S Eltonsy, L Haidar, L N Drumright, J Ma, K H Mayer, S Napravnik, J J Eron, K A Christopoulos und 14 weitere

Diabetes Care · 01.10.2025 · 48 (10) · 1761-1765

DOI: 10.2337/dc25-0236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 19.09.2025. Verfasst von Andrew W Hahn und 25 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington, Seattle, WA. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, HIV Infections, Hypoglycemic Agents, Healthcare Disparities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To evaluate semaglutide use among people with HIV (PWH) with medical indications by race and ethnicity. RESEARCH DESIGN AND METHODS We identified PWH in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort at nine sites eligible for semaglutide therapy between 2019 and 2023. Semaglutide eligibility was based on BMI ≥30 or HbA1c ≥6.5. We evaluated differences in semaglutide receipt among eligible PWH by race and ethnicity using relative risk regression adjusted for demographic characteristics. RESULTS Among 11,617 eligible PWH, 774 (6.7%) received semaglutide (92% eligible by BMI ≥30, 62% by HbA1c ≥6.5, and 54% by both criteria). Eligible Black PWH were 20% less likely to receive semaglutide versus White PWH (prevalence ratio [PR] 0.80, 95% CI 0.67–0.95). The lower rate of semaglutide for Black (PR 0.66, 95% CI 0.53–0.83) and Hispanic PWH (PR 0.70, 95% CI 0.53–0.93) was more pronounced among those with higher HbA1c (≥8.0). CONCLUSIONS We describe inequitable semaglutide use among PWH, with lower initiation rates in eligible Black PWH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesHIV InfectionsHypoglycemic AgentsHealthcare DisparitiesHumansFemaleMaleMiddle AgedAdultBlack or African AmericanWhite PeopleGlycated HemoglobinHispanic or LatinoWhiteGlucagon-Like Peptide 1Semaglutide

Substanzen

Glucagon-Like PeptidesHypoglycemic AgentsGlycated HemoglobinGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • University of Washington, Seattle, WA.
  • University of Manitoba, Winnipeg, Manitoba, CA.
  • The Fenway Institute, Harvard Medical School, Boston, MA.
  • University of North Carolina, Chapel Hill, NC.
  • University of California San Francisco, San Francisco, CA.
  • University of California San Diego, La Jolla, CA.

ORCID-Profile: Andrew W Hahn

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIDA NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Heart, Lung, and Blood Institute
  • National Institute on Drug Abuse

Zitieren

APA

Hahn, A. W., Ruderman, S. A., Nance, R. M., Whitney, B. M., Eltonsy, S., Haidar, L., Drumright, L. N., Ma, J., Mayer, K. H., Napravnik, S., Eron, J. J., Christopoulos, K. A., Bamford, L., Cachay, E. R., Yendewa, G., Pettit, A., Saag, M. S., Heath, S. L., Moore, R. D., …, & Fredericksen, R. J. (2025). Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV. Diabetes Care, 48(10), 1761-1765. https://doi.org/10.2337/dc25-0236

Vancouver

Hahn AW, Ruderman SA, Nance RM, Whitney BM, Eltonsy S, Haidar L, et al. Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV. Diabetes Care. 2025;48(10):1761-1765. doi:10.2337/dc25-0236

BibTeX
@article{Hahn2025,
  author = {Hahn, Andrew W and Ruderman, S A and Nance, R M and Whitney, B M and Eltonsy, S and Haidar, L and Drumright, L N and Ma, J and Mayer, K H and Napravnik, S and Eron, J J and Christopoulos, K A and Bamford, L and Cachay, E R and Yendewa, G and Pettit, A and Saag, M S and Heath, S L and Moore, R D and Keruly, J C and Batey, D S and Chander, G and Kitahata, M M and Delaney, J A C and Crane, H M and Fredericksen, R J},
  title = {Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV},
  journal = {Diabetes Care},
  year = {2025},
  volume = {48},
  number = {10},
  pages = {1761--1765},
  doi = {10.2337/dc25-0236}
}
Kostenlos starten →